|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-2-7
|
|
pubmed:abstractText |
Cardiovascular disease is the most common cause of mortality in patients with end-stage renal disease. Cardiovascular benefits of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been clearly established in the general population, but not in dialysis patients. This study examined statin prescription patterns and assessed the relationship between statin prescription and clinical outcomes in hemodialysis (HD) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
pubmed-author:AkibaTakashiT,
pubmed-author:AkizawaTadaoT,
pubmed-author:BailieGeorge RGR,
pubmed-author:Bragg-GreshamJennifer LJL,
pubmed-author:CombeChristianC,
pubmed-author:GillespieBrenda WBW,
pubmed-author:MasonNancy ANA,
pubmed-author:RaynerHugh CHC,
pubmed-author:SaitoAkiraA,
pubmed-author:SatayathumSudtidaS,
pubmed-author:YoungEric WEW
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
119-26
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15696451-Comorbidity,
pubmed-meshheading:15696451-Drug Prescriptions,
pubmed-meshheading:15696451-Female,
pubmed-meshheading:15696451-France,
pubmed-meshheading:15696451-Germany,
pubmed-meshheading:15696451-Great Britain,
pubmed-meshheading:15696451-Humans,
pubmed-meshheading:15696451-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:15696451-Italy,
pubmed-meshheading:15696451-Japan,
pubmed-meshheading:15696451-Kidney Failure, Chronic,
pubmed-meshheading:15696451-Longitudinal Studies,
pubmed-meshheading:15696451-Male,
pubmed-meshheading:15696451-Middle Aged,
pubmed-meshheading:15696451-Observation,
pubmed-meshheading:15696451-Proportional Hazards Models,
pubmed-meshheading:15696451-Prospective Studies,
pubmed-meshheading:15696451-Renal Dialysis,
pubmed-meshheading:15696451-Risk Assessment,
pubmed-meshheading:15696451-Spain,
pubmed-meshheading:15696451-United States
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.
|
|
pubmed:affiliation |
College of Pharmacy, University of Michigan, College of Pharmacy, Ann Arbor, MI 48109-1065, USA. nmason@umich.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
